Seagen said that the antibody in its ADC may be superior to trastuzumab, as it has a higher affinity for HER2 and gets into cells more effectively, although that will have to be put to the test in ...
Unveiled updates across proprietary pipeline and demonstrated new breakthroughs by AI platform at 2024 R&D Day Entered into collaboration with AMD, including $20 million strategic investment in Absci ...
Yelena Y. Janjigian, MD, discusses the standard approval of pembrolizumab plus trastuzumab and chemotherapy for the treatment ...
In HER2-positive early breast cancer, Kadcyla shows sustained improvement in both invasive disease-free survival and overall ...
HER2-positive breast cancer, once associated with poor outcomes, now sees improved prognosis due to targeted therapies like Herceptin. Combination therapies and neoadjuvant treatments have enhanced ...
They are widely used for: HER2-Positive Breast Cancer: The most common indication for Herceptin biosimilars, improving survival rates in breast cancer patients. HER2-Positive Gastric Cancer ...
Background: Variable rates of HER2 protein overexpression and gene amplification have been reported in advanced ovarian cancers (AOC). Trastuzumab, tested only as a single agent, has been shown to ...
The FDA has approved Amgen and Allergan’s biosimilar of Roche’s Herceptin, just in time for the breast cancer blockbuster’s patent expiry. Herceptin’s main US patent expires this month ...
Affinity is an important stat in Monster Hunter Wilds, but it's unfortunately hard to come by useful information about it in-game. So to help you understand this deceptively simple stat, we've got ...
Experts discuss the patient case of Janet, a 58-year-old with her 2 positive metastatic breast cancer, and after 14 months on ...
While many stats like the Attack number and different elemental effects are pretty straightforward, the Affinity stat doesn’t immediately explain itself. This is arguably the most important stat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results